Researchers in the Appel lab have developed hydrogels for tumor inoculation that improve precision and statistical power in preclinical mouse models of cancer.
This invention is an intraoral palate expanding plate with an expansion screw for both cleft palate and restricted airways that can be produced by 3-D printing and CT scans.
A team of Stanford computer scientists have developed software that can serve as a key enabling technology for location-aware services indoors. Location-aware services are an important emerging technology for mobile devices.
Researchers at Stanford have found that nascent polypeptide-associated complex (NAC) and the apical domain of CCT1, as well as peptide fragments and fusion proteins containing them, can be used to suppress pathological protein aggregation.
Stanford inventor Dr. Anne Liu has developed an algorithm that can assess the risk of allergic reaction to antibiotics and help clinicians make decisions about which antibiotic to prescribe in patients who have a history of antibiotic allergies at the point-of-care.
Researchers at Stanford have developed a process for modifying metal powder stock to enable printing of high reflectivity metals using moderate laser powers (200-400 W) in commercially available printing systems (200-400W).
Stanford researchers have constructed a microbial cell factory by genetically modifying the bacterium Methylomicrobium alcaliphilum 20Z to convert methanol and methane into para-hydroxybenzoic acid (p-HBA).
Stanford researchers designed and built a light sheet microscope that can be used for deconvolution-free, high resolution volumetric imaging of cleared tissue specimens.
Optimizing battery performance currently relies on empirical testing using arbitrary parameters, under-validated physiochemical models, and limited data analysis of summary trends.
Researchers at Stanford University have developed a deep learning software algorithm that allows physicians running clinical trials to predict control patient outcomes using virtual control arms.
Jennifer Cochran and Carolyn Bertozzi have collaborated to develop a bifunctional molecule called a polyspecific integrin-binding peptide (PIP)-LYTAC that can bind to integrins expressed on the surface of cancer cells and trigger their degradation via the lysosome.